Recent Company News

• 03:04 AM ET Apr 28, 2025
  

  Ono Pharmaceutical guides FY net income attributable ¥50.00B vs prior guidance ¥58.00B and FactSet ¥63.51B [10 est, ¥58.50-69.10B] (¥1650.5000, 0)

• 08:03 PM ET Apr 23, 2025
  

  Ono Pharmaceutical to present positive results from Phase 2 PROSPECT study of tirabrutinib (ONO-4059) at ASCO (¥1683.5000, -12.5)

• 09:04 AM ET Apr 21, 2025
  

  Ono Pharmaceutical commences research collaboration with Jorna Therapeutics to generate novel RNA editing therapeutics (¥1736.5000, 0)

• 10:02 PM ET Apr 08, 2025
  

  Follow-up: US President Donald Trump says the US will unveil "major" tariff on imports of pharmaceutical goods - NBC News

• 10:52 PM ET Mar 11, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 08:02 AM ET Mar 28, 2025
  

  Bristol Myers Squibb confirms positive CHMP opinion for Opdivo SC ($58.90, 0.00)

• 07:36 AM ET Mar 28, 2025
  

  EU's CHMP adopted a positive opinion recommending a change to the terms of the marketing authorisation for Opdivo ($58.90, 0.00)

• 07:33 AM ET Mar 28, 2025
  

  EU's CHMP adopted a positive opinion recommending recommending a change to the terms of the marketing authorisation for Opdivo ($58.90, 0.00)